Human gene editing: revisiting Canadian policy

Affiliations

¹ Centre of Genomics and Policy, McGill University, Montreal, QC Canada.
² Department of Human Genetics, Institute for Bioethics and Health Policy, John P. Hussman Institute for Human Genomics, Interdisciplinary Stem Cell Institute, Miami, FL USA.
³ Health Law Institute, University of Alberta, Edmonton, AB Canada.
⁴ Clinical Translation and Regulatory Affairs, Centre for Commercialisation of Regenerative Medicine (CCRM), Toronto, ON Canada.
⁵ National Core for Neuroethics, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC Canada.
⁶ Faculty of Law and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB Canada.
⁷ Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC Canada.
⁸ Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON Canada.
⁹ Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON Canada.

Editorial

Bartha Maria Knoppers et al. NPJ Regen Med. 2017.

. 2017 Jan 5:2:3.

doi: 10.1038/s41536-017-0007-2. eCollection 2017.

¹ Centre of Genomics and Policy, McGill University, Montreal, QC Canada.
² Department of Human Genetics, Institute for Bioethics and Health Policy, John P. Hussman Institute for Human Genomics, Interdisciplinary Stem Cell Institute, Miami, FL USA.
³ Health Law Institute, University of Alberta, Edmonton, AB Canada.
⁴ Clinical Translation and Regulatory Affairs, Centre for Commercialisation of Regenerative Medicine (CCRM), Toronto, ON Canada.
⁵ National Core for Neuroethics, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC Canada.
⁶ Faculty of Law and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB Canada.
⁷ Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC Canada.
⁸ Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON Canada.
⁹ Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON Canada.

No abstract available

References

1. Isasi R, Kleiderman E, Knoppers BM. Editing policy to fit the genome? Science. 2016;351:337–339. doi: 10.1126/science.aad6778. - DOI - PubMed
1. Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 2016;34:933–941. doi: 10.1038/nbt.3659. - DOI - PubMed
1. Wright AV, Nuñez JK, Doudna JA. Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell. 2016;164:29–44. doi: 10.1016/j.cell.2015.12.035. - DOI - PubMed
1. Nuffield Council on Bioethics. Genome editing: an ethical review. London, pp 1–128, http:/nuffieldbioethics.org/wpcontent/ uploads/Genome-editing-an-ethical... (2016).
1. Royal Commission on New Reproductive Technologies. Proceed with care: final report. Ottawa (1993).